RNA interference and its therapeutic potential against HIV infection

Expert Opinion on Biological Therapy

Volumn 8, Issue 4, 2008, Pages 449-461

  Singh, Sunit K ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

HIV; RNA interference; siRNA; Small RNAs

Indexed keywords

ANTIRETROVIRUS AGENT; SMALL INTERFERING RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COMPLEX FORMATION; DISEASE COURSE; GENE EXPRESSION; GENE SILENCING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; REVIEW; RNA INTERFERENCE; VIRUS ENTRY; VIRUS REPLICATION; ANIMAL; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; METHODOLOGY; PATHOGENICITY; T LYMPHOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMALS; GENE EXPRESSION REGULATION, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; HIV INFECTIONS; HIV-1; HUMANS; RNA INTERFERENCE; RNA, SMALL INTERFERING; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 42149187167     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.8.4.449     Document Type: Review

References (105)

1. Saag MS, Kilby JM. HIV-1 and HAART: a time to cure, a time to kill. Nat Med 1999;5(6):609-11
2. Voss G, Villinger F. Adjuvanted vaccine strategies and live vector approaches for the prevention of AIDS. AIDS 2000;14(Suppl 3):S153-65
3. Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: strike and counterstrike. Nat Biotechnol 2007;25(12):1435-43
4. van Rij RP, Andino R. The silent treatment: RNAi as a defense against virus infection in mammals. Trends Biotechnol 2006;24(4):186-93
5. Dalgleish AG, Beverley PC, Clapham PR, et al. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984;312(5996):763-7
6. Klatzmann D, Champagne E, Chamaret S, et al. T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 1984;312(5996):767-8
7. Maddon P, Dalgleish A, McDougal J, et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986;47:333-48
8. Cocchi F, DeVico AL, Garzino-Demo A, et al. Identification of RANTES, MIP-1α, and MIP-1β as the major HIV-suppressive factors produced by CD8+ T cells. Science 1995;270(5243):1811-5 •• Provides excellent information on major HIV suppressive factors.
9. Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature 1996;381(6584):661-6
10. Doranz BJ, Rucker J, Yi Y, et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85(7):1149-58
11. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272(5263):872-7
12. Deng HK, Unutmaz D, KewalRamani VN, Littman DR. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 1997;388(6639):296-300
13. Liao F, Alkhatib G, Peden KW, et al. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J Exp Med 1997;185(11):2015-23
14. Zack JA, Arrigo SJ, Weitsman SR, et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990;61(2):213-22
15. Capodici J, Kariko K, Weissman D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J Immunol 2002;169(9):5196-201 • Demonstrates the ability of siRNAs to inhibit HIV-1 infection.
16. Coburn GA, Cullen BR. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J Virol 2002;76(18):9225-31 • Very good article demonstrating the effectiveness of siRNAs against HIV-1.
17. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002;418(6896):435-8
18. Nishitsuji H, Ikeda T, Miyoshi H, et al. Expression of small hairpin RNA by lentivirus-based vector confers efficient and stable gene-suppression of HIV-1 on human cells including primary non-dividing cells. Microbes Infect 2004;6(1):76-85
19. Hu WY, Myers CP, Kilzer JM, et al. Inhibition of retroviral pathogenesis by RNA interference. Curr Biol 2002;12(15):1301-11
20. Surabhi RM, Gaynor RB. RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication. J Virol 2002;76(24):12963-73
21. Westerhout EM, ter Brake O, Berkhout B. The virion-associated incoming HIV-1 RNA genome is not targeted by RNA interference. Retrovirology 2006;3:57. Published online September 4 2006, doi:10.1186/1742-4690-3-57 •• This paper shows that the incoming HIV-1 RNA genome is protected from RNAi during the infection of the cell.
22. Li CJ. Therapeutic biology: checkpoint pathway activation therapy, HIV Tat, and transkingdom RNA interference. J Cell Physiol 2006;209(3):695-700
23. Naito Y, Nohtomi K, Onogi T, et al. Optimal design and validation of antiviral siRNA for targeting HIV-1. Retrovirology 2007;4(1):80. Published online November 8 2007, doi:10.1186/1742-4690-4-80 •• This article describes the exhaustive characterization of siRNA targets conserved between different strains of HIV-1.
24. Ge Q, McManus MT, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003;100(5):2718-23
25. Kapadia SB, Brideau-Andersen A, Chisari FV. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA 2003;100(4):2014-8 • Good paper on effectiveness of siRNA in blocking HCV replication.
26. Zhang Y, Li T, Fu L, et al. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference. FEBS Lett 2004;560(1-3):141-6
27. Yoshinouchi M, Yamada T, Kizaki M, et al. In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA. Mol Ther 2003;8(5):762-8
28. McCown M, Diamond MS, Pekosz A. The utility of siRNA transcripts produced by RNA polymerase i in down regulating viral gene expression and replication of negative- and positive-strand RNA viruses. Virology 2003;313(2):514-24
29. Jopling CL, Yi M, Lancaster AM, et al. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005;309(5740):1577-81 • Provides detailed information on interaction of miRNA and HCV.
30. Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 2007;133(4):1166-74
31. Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007;449(7164):919-22 •• This article describes the role of miRNAs as mediators of the interferon antiviral defense in mammalian cells.
32. Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4(+) T lymphocytes. Nat Med 2007;13(10):1241-7 •• Excellent article on the role of miRNAs in maintaining HIV-1 latency.
33. Triboulet R, Mari B, Lin YL, et al. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007;315(5818):1579-82 • Good article on suppression of the miRNA pathway by HIV-1.
34. Song E, Zhu P, Lee SK, et al. Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat Biotechnol 2005;23(6):709-17
35. Lee SK, Dykxhoorn DM, Kumar P, et al. Lentiviral delivery of short hairpin RNAs protects CD4 T cells from multiple clades and primary isolates of HIV. Blood 2005;106(3):818-26
36. Chang LJ, Liu X, He J. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1. Gene Ther 2005;12(14):1133-44 • Very good description of siRNA targeting of conserved sequences of HIV-1.
37. Barnor JS, Miyano-Kurosaki N, Yamaguchi K, et al. Lentiviral-mediated delivery of combined HIV-1 decoy TAR and Vif siRNA as a single RNA molecule that cleaves to inhibit HIV-1 in transduced cells. Nucleosides Nucleotides Nucleic Acids 2005;24(5-7):431-4
38. Lee MT, Coburn GA, McClure MO, Cullen BR. Inhibition of human immunodeficiency virus type 1 replication in primary macrophages by using Tat- or CCR5-specific small interfering RNAs expressed from a lentivirus vector. J Virol 2003;77(22):11964-72
39. Dave RS, Pomerantz RJ. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains. J Virol 2004;78(24):13687-96
40. Li MJ, Kim J, Li S, et al. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol Ther 2005;12(5):900-9
41. Park J, Nadeau P, Zucali JR, et al. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs. Virology 2005;343(2):275-82
42. Park WS, Hayafune M, Miyano-Kurosak IN, Takaku H. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells. Gene Ther 2003;10(24):2046-50
43. Puerta-Fernandez E, Barroso-del Jesus A, Romero-López C, et al. Inhibition of HIV-1 replication by RNA targeted against the LTR region. AIDS 2005;19(9):863-70
44. Novina CD, Murray MF, Dykxhoorn DM, et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002;8(7):681-6
45. Park WS, Miyano-Kurosaki N, Hayafune M, et al. Prevention of HIV-1 infection in human peripheral blood mononuclear cells by specific RNA interference. Nucleic Acids Res 2002;30(22):4830-5
46. Kitabwalla M, Ruprecht RM. RNA interference - a new weapon against HIV and beyond. N Engl J Med 2002;347(17):1364-7
47. Martinez MA, Gutiérrez A, Armand-Ugón M, et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 2002;16(18):2385-90
48. Qin XF, An DS, Chen IS, Baltimore D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci USA 2003;100(1):183-8
49. Komano J, Miyauchi K, Matsuda Z, Yamamoto N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol Biol Cell 2004;15(12):5197-207
50. Kameoka M, Nukuzuma S, Itaya A, et al. RNA interference directed against Poly(ADP-Ribose) polymerase 1 efficiently suppresses human immunodeficiency virus type 1 replication in human cells. J Virol 2004;78(16):8931-4
51. Chiu YL, Cao H, Jacque JM, et al. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1). J Virol 2004;78(5):2517-29. Published online December 27 2004, doi:10.1186/1742-4690-1- 46
52. Ping YH, Chu CY, Cao H, et al. Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology 2004;1:46. Published online 27 December 2004, doi:10.1186/1742- 4690-1-46
53. Garrus JE, von Schwedler UK, Pornillos OW, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001;107(1):55-65
54. Stevenson M. Dissecting HIV-1 through RNA interference. Nat Rev Immunol 2003;3(11):851-8
55. Yu Z, Sánchez-Velar N, Catrina IE, et al. The cellular HIV-1 Rev cofactor hRIP is required for viral replication. Proc Natl Acad Sci USA 2005;102(11):4027-32
56. Modem S, Badri KR, Holland TC, Reddy TR. Sam68 is absolutely required for Rev function and HIV-1 production. Nucleic Acids Res 2005;33(3):873-9
57. Wang QC, Nie QH, Feng ZH. RNA interference: antiviral weapon and beyond. World J Gastroenterol 2003;9(8):1657-61
58. Liu S, Asparuhova M, Brondani V, et al. Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A. Nucleic Acids Res 2004;32(12):3752-9
59. Hauber I, Bevec D, Heukeshoven J, et al. Identification of cellular deoxyhypusine synthase as a novel target for antiretroviral therapy. J Clin Invest 2005;115(1):76-85
60. Pollard VW, Malim MH. The HIV-1 Rev protein. Ann Rev Microbiol 1998;52:491-532
61. Ward DM, Vaughn MB, Shiflett SL, et al. The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem 2005;280(11):10548-55
62. Nibbs RJ, Kriehuber E, Ponath PD, et al. The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol 2001;158(3):867-77
63. Neil SJ, Aasa-Chapman MM, Clapham PR, et al. The promiscuous CC chemokine receptor D6 is a functional coreceptor for primary isolates of human immunodeficiency virus type 1 (HIV-1) and HIV-2 on astrocytes. J Virol 2005;79(15):9618-24
64. Moore JP. Coreceptors: implications for HIV pathogenesis and therapy. Science 1997;276(5309):51-2
65. Brass LA, Dykxhoorn DM, Benita Y, et al. Identification of host protein required for HIV infection through a functional genomic screen. Science 2008;319:921-6 •• Excellent report on host proteins required for HIV infection.
66. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003;4(5):346-58 • Good description of potential problems associated with the use of viral vectors in gene therapy.
67. Kim DH, Rossi JJ. Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007;8(3):173-84 •• Excellent paper on the role of RNAi in combating human diseases.
68. Soutschek J, Akinc A, Bramlage B, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004;432(7014):173-8
69. Bitko V, Musiyenko A, Shulyayeva O, Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat Med 2005;11(1):50-5
70. Zhang W, Yang H, Kong X, et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005;11(1):56-62
71. Giladi H, Ketzinel-Gilad M, Rivkin L, et al. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 2003;8(5):769-76
72. Michienzi A, Castanotto D, Lee N, et al. RNA-mediated inhibition of HIV in a gene therapy setting. Ann NY Acad Sci 2003;1002:63-71
73. Gitlin L, Karelsky S, Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002;418(6896):430-4
74. Sullivan CS, Grundhoff AT, Tevethia S, et al. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005;435(7042):682-6
75. Han Y, Siliciano RF. Keeping quiet: microRNAs in HIV-1 latency. Nat Med 2007;13(10):1138-40
76. Haasnoot J, de Vries W, Geutjes EJ, et al. The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog 2007;3(6):e86. Published online June 22 2007, doi:10.1371/journal.ppat.0030086
77. Bennasser Y, Le SY, Benkirane M, Jeang KT. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 2005;22(5):607-19
78. Berkhout B, Jeang KT. Detailed mutational analysis of TAR RNA: critical spacing between the bulge and loop recognition domains. Nucleic Acids Res 1991;19(22):6169-76
79. Bennasser Y, Yeung ML, Jeang KT. RNAi therapy for HIV infection: principles and practicalities. BioDrugs 2007;21(1):17-22
80. Bennasser Y, Yeung ML, Jeang KT. HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J Biol Chem 2006;281(38):27674-8
81. Gatignol A, Laine S, Clerzius G. Dual role of TRBP in HIV replication and RNA interference: viral diversion of a cellular pathway or evasion from antiviral immunity? Retrovirology 2005;2:65. Published online 27 October 2005, doi:10.1186/1742-4690-2-65
82. Rossi JJ. RNAi as a treatment for HIV-1 infection. Biotechniques 2006;(Suppl):25-9
83. Yeung ML, Bennasser Y, Myers TG, et al. Changes in microRNA expression profiles in HIV-1-transfected human cells. Retrovirology 2005;2:81. Published online 28 December 2005, doi:10.1186/1742-4690-2-81
84. Williams BR. PKR; a sentinel kinase for cellular stress. Oncogene 1999;18(45):6112-20
85. Nekhai S, Jerebtsova M. Therapies for HIV with RNAi. Curr Opin Mol Ther 2006;8(1):52-61
86. Ong CL, Thorpe JC, Gorry PR, et al. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol 2005;79(20):12763-72
87. Scherer L, Rossi JJ, Weinberg MS. Progress and prospects: RNA-based therapies for treatment of HIV infection. Gene Ther 2007;14(14):1057-64
88. Boden D, Pusch O, Lee F, et al. Human immunodeficiency virus type 1 escape from RNA interference. J Virol 2003;77(21):11531-5
89. Berkhout B. RNA interference as an antiviral approach: targeting HIV-1. Curr Opin Mol Ther 2004;6(2):141-5
90. Das AT, Brummelkamp TR, Westerhout EM, et al. Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J Virol 2004;78(5):2601-5
91. Westerhout EM, Ooms M, Vink M, et al. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005;33(2):796-804
92. ter Brake O, Konstantinova P, Ceylan M, Berkhout B. Silencing of HIV-1 with RNA interference: a multiple shRNA approach. Mol Ther 2006;14(6):883-92
93. Leonard JN, Schaffer DV. Computational design of antiviral RNA interference strategies that resist human immunodeficiency virus escape. J Virol 2005;79(3):1645-54
94. Jackson AL, Burchard J, Schelter J, et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. RNA 2006;12(7):1179-87
95. Birmingham A, Anderson EM, Reynolds A, et al. 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 2006;3(3):199-204
96. Singh SK, Girschick HJ. Toll-like receptors in Borrelia burgdorferi-induced inflammation. Clin Microbiol Infect 2006;12(8):705-17
97. Grimm D, Streetz KL, Jopling CL, et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways. Nature 2006;441(7092):537-41
98. Arrighi JF, Pion M, Wiznerowicz M, et al. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells. J Virol 2004;78(20):10848-55
99. Anderson J, Akkina R. HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector. AIDS Res Ther 2005;2(1):1
100. Dunn SJ, Khan IH, Chan UA, et al. Identification of cell surface targets for HIV-1 therapeutics using genetic screens. Virology 2004;321(2):260-73
101. Liu B, Sarkis PT, Luo K, et al. Regulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase. J Virol 2005;79(15):9579-87
102. Ye Y, De Leon J, Yokoyama N, et al. DBR1 siRNA inhibition of HIV-1 replication. Retrovirology 2005;2:63. Published online 18 October 2005, doi:10.1186/1742-4690-2-63
103. Li Z, Xiong Y, Peng Y, et al. Specific inhibition of HIV-1 replication by short hairpin RNAs targeting human cyclin T1 without inducing apoptosis. FEBS Lett 2005;579(14):3100-6
104. Liang WS, Maddukuri A, Teslovich TM, et al. Therapeutic targets for HIV-1 infection in the host proteome. Retrovirology 2005;2:20. Published online 21 March 2005, doi:10.1186/1742-4690-2-20
105. Ammosova T, Berro R, Kashanchi F, Nekhai S. RNA interference directed to CDK2 inhibits HIV-1 transcription. Virology 2005;341(2):171-8